While setting aside yesterday's turmoil in the U.S. market, several companies in Japan successively announced approvals, upward revisions and the launch of new AI businesses, drawing attention to individual stock movements.
The Dow fell sharply in yesterday's U.S. stock market, while the Nasdaq edged lower, increasing uncertainty in the market. In response, a succession of announcements concerning approvals, upward revisions and new AI-related initiatives highlighted stocks in the Japanese market.
Specifically, 富士製薬 obtained manufacturing and marketing approval for a biosimilar, while 弁護士コム announced that its LegalBrain agent had been listed in the connector directory for the generative AI platform Claude. In addition, 電算's first-half forecast was revised upward, and several companies including JustPla raised their medium-term and full-year forecasts, with buying interest in related stocks expected to increase.
レダックス announced a sponsorship agreement with ハリカ社, which oversees a gift chain, while オリチエン工業 announced the launch of its X-AI project combining AI and digital technologies. These developments may attract attention as factors influencing stock selection in the market.